Active substance
Prazosin
- SFDA 6
- US FDA 29
- Health Canada 6
- US price lines 3
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MINIPRESS TAB 1MG | 1 mg | Tablet · Oral use | 100 Blister | SAR 22.95 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| MINIPRESS TAB 1MG | 1 mg | Tablet · Oral use | 30 Blister | SAR 11.95 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| MINIPRESS TAB 2MG | 2 mg | Tablet · Oral use | 100 Blister | SAR 38.35 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| MINIPRESS TAB 2MG | 2 mg | Tablet · Oral use | 30 Blister | SAR 19.90 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| MINIPRESS TAB 5MG | 5 mg | Tablet · Oral use | 100 Blister | SAR 67.55 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| MINIPRESS TAB 5MG | 5 mg | Tablet · Oral use | 30 Blister | SAR 22.80 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MINIPRESS | EQ 5MG BASE; EQ 1MG BASE; EQ 2MG BASE | capsule · oral | PFIZER | Prescription | 23 Jun 1976 |
| PRAZOSIN HYDROCHLORIDE | EQ 5MG BASE; EQ 1MG BASE; EQ 2MG BASE | capsule · oral | TEVA PHARMS | Prescription | 12 Sep 1988 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE | capsule · oral | IVAX SUB TEVA PHARMS | Prescription | 12 Sep 1988 |
| PRAZOSIN HYDROCHLORIDE | EQ 2MG BASE | capsule · oral | TEVA PHARMS | Prescription | 12 Sep 1988 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE | capsule · oral | MYLAN | Prescription | 28 Feb 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 2MG BASE | capsule · oral | MYLAN | Prescription | 28 Feb 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 5MG BASE; EQ 2MG BASE; EQ 1MG BASE | capsule · oral | MYLAN | Prescription | 28 Feb 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | NOVITIUM PHARMA | Prescription | 3 Oct 2018 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | GRANULES | Prescription | 23 Dec 2021 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | APPCO | Prescription | 21 Oct 2022 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | MANKIND PHARMA | Prescription | 30 Dec 2022 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | ALEMBIC | Prescription | 6 Mar 2023 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | AUROBINDO PHARMA LTD | Prescription | 31 Mar 2023 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | MSN | Prescription | 17 Sep 2024 |
| PRAZOSIN HYDROCHLORIDE | EQ 2MG BASE | capsule · oral | WATSON LABS | Discontinued | 11 Jan 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE | capsule · oral | WATSON LABS | Discontinued | 11 Jan 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 5MG BASE | capsule · oral | WATSON LABS | Discontinued | 11 Jan 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE | capsule · oral | DAVA PHARMS INC | Discontinued | 15 Mar 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 2MG BASE | capsule · oral | DAVA PHARMS INC | Discontinued | 15 Mar 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 5MG BASE | capsule · oral | DAVA PHARMS INC | Discontinued | 15 Mar 1989 |
| PRAZOSIN HYDROCHLORIDE | EQ 2MG BASE; EQ 1MG BASE; EQ 5MG BASE | capsule · oral | ANI PHARMS | Discontinued | 10 Apr 1989 |
| MINIPRESS XL | 2.5MG; 5MG | tablet, extended release · oral | PFIZER | Discontinued | 29 Jan 1992 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASE | capsule · oral | LANNETT CO INC | Discontinued | 3 Jan 2024 |
| PRAZOSIN HYDROCHLORIDE | EQ 1MG BASE | capsule · oral | AM THERAP | Discontinued | |
| PRAZOSIN HYDROCHLORIDE | EQ 2MG BASE | capsule · oral | AM THERAP | Discontinued |
4 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-PRAZO | 00882801 | 1 MG | TABLET · ORAL | APOTEX INC |
| APO-PRAZO | 00882828 | 2 MG | TABLET · ORAL | APOTEX INC |
| APO-PRAZO | 00882836 | 5 MG | TABLET · ORAL | APOTEX INC |
| TEVA-PRAZOSIN | 01934198 | 1 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-PRAZOSIN | 01934201 | 2 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-PRAZOSIN | 01934228 | 5 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | PRAZOSIN 1 MG CAPSULE | $0.08417 | per EA | 23 Sep 2026 |
| US NADAC | PRAZOSIN 2 MG CAPSULE | $0.08634 | per EA | 23 Sep 2026 |
| US NADAC | PRAZOSIN 5 MG CAPSULE | $0.13371 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Prazosin 500microgram tablets | £2.69 | 60 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.